Privia Health Group (PRVA) Stock Price, News & Analysis

Company Overview

Privia Health Group, Inc. is a physician-enablement company that supports independent medical practices through technology, administrative services and value-based care programs. The company partners with physicians and medical groups to help them manage clinical operations, improve patient outcomes and participate in alternative payment arrangements with health insurers and employers.

Its platform includes practice management and electronic health record tools, data analytics, population health management, care coordination, revenue cycle support, payer contracting and centralized administrative services. Privia also helps affiliated providers form and operate medical groups, develop specialty and primary care networks, and transition from fee-for-service models toward value-based care.

Founded in 2007 and headquartered in Arlington, Virginia, Privia serves physician practices and patients across multiple U.S. markets. The company became a publicly traded business on the Nasdaq in 2021. Its affiliated providers include primary care physicians and specialists operating through regional medical groups and other care-delivery organizations.

Key Stats

• Today's Range: $19.96 to $20.33
• 50-Day Range: $19.10 to $24.83
• 52-Week Range: $18.92 to $28.82
• Volume: 1.17 million shs
• Average Volume: 1.24 million shs
• Market Capitalization: $2.59 billion
• P/E Ratio: 96.67
• Dividend Yield: N/A
• Price Target: $31.00
• Consensus Rating: Moderate Buy

Privia Health Group Stock Analysis - MarketRank™

Privia Health Group scored higher than 93% of companies evaluated by MarketBeat, and ranked 23rd out of 887 stocks in the healthcare sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 4.0 / 5
• Analyst Rating: Moderate Buy

Consensus Rating

Privia Health Group has received a consensus rating of Moderate Buy. The company's average rating score is 2.79, and is based on no strong buy ratings, 11 buy ratings, 3 hold ratings, and no sell ratings.

Upside Potential

Privia Health Group has a consensus price target of $31.00, representing about 52.7% upside from its current price of $20.30.

Amount of Analyst Coverage

Privia Health Group has only been the subject of 3 research reports in the past 90 days.

Earnings and Valuation

• Score: 2.5 / 5
• Proj. Earnings Growth: 51.85%

Earnings Growth

Earnings for Privia Health Group are expected to grow by 51.85% in the coming year, from $0.27 to $0.41 per share.

Price to Earnings Ratio vs. the Market

The P/E ratio of Privia Health Group is 96.67, which means that it is trading at a more expensive P/E ratio than the market average P/E ratio of about 44.66.

Price to Earnings Ratio vs. Sector

The P/E ratio of Privia Health Group is 96.67, which means that it is trading at a less expensive P/E ratio than the Healthcare sector average P/E ratio of about 274.69.

Price to Book Value per Share Ratio

Privia Health Group has a P/B Ratio of 3.16. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

Short Interest

• Score: 5.0 / 5
• Short Interest Level: Healthy

Percentage of Shares Shorted

4.07% of the float of Privia Health Group has been sold short.

Short Interest Ratio / Days to Cover

Privia Health Group has a short interest ratio ("days to cover") of 3.96, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in Privia Health Group has recently decreased by 10.16%, indicating that investor sentiment is improving significantly.

Dividend

• Score: 0.0 / 5
• Dividend Strength: N/A

Dividend Yield

Privia Health Group does not currently pay a dividend.

Dividend Growth

Privia Health Group does not have a long track record of dividend growth.

News and Social Media

• Score: 2.9 / 5
• News Sentiment: 0.71

News Sentiment

Privia Health Group has a news sentiment score of 0.71. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.44 average news sentiment score of Healthcare companies.

News Coverage This Week

MarketBeat has tracked 2 news articles for Privia Health Group this week, compared to 4 articles on an average week.

Search Interest

1 people have searched for PRVA on MarketBeat in the last 30 days.

MarketBeat Follows

Only 1 people have added Privia Health Group to their MarketBeat watchlist in the last 30 days. This is a decrease of -50% compared to the previous 30 days.

Company Ownership

• Score: 1.6 / 5
• Insider Trading: Selling Shares

Insider Buying vs. Insider Selling

In the past three months, Privia Health Group insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $2,068,609.00 in company stock.

Percentage Held by Insiders

5.70% of the stock of Privia Health Group is held by insiders.

Percentage Held by Institutions

94.48% of the stock of Privia Health Group is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

Company Calendar

• Last Earnings: 8/06/2026
• Today: 10/04/2026
• Next Earnings (Estimated): 11/05/2026
• Fiscal Year End: 12/31/2026

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Healthcare
• Industry: Healthcare Providers & Services
• Sub-Industry: Healthcare Services
• Current Symbol: NASDAQ:PRVA
• CIK: 1759655
• Web: www.priviahealth.com
• Phone: 571-366-8850
• Fax: N/A
• Employees: 1,226
• Year Founded: 2007

Price Target and Rating

• Average Price Target for Privia Health Group: $31.00
• High Price Target: $36.00
• Low Price Target: $24.00
• Potential Upside/Downside: +52.7%
• Consensus Rating: Moderate Buy
• Rating Score (0-4): 2.79
• Research Coverage: 14 Analysts

Profitability

• EPS (Trailing Twelve Months): $0.21
• Trailing P/E Ratio: 96.67
• Forward P/E Ratio: 75.19
• P/E Growth: N/A
• Net Income: $22.92 million
• Net Margins: 1.19%
• Pretax Margin: 2.38%
• Return on Equity: 3.52%
• Return on Assets: 2.00%

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: 1.62
• Quick Ratio: 1.62

Sales & Book Value

• Annual Sales: $2.12 billion
• Price / Sales: 1.22
• Cash Flow: $0.27 per share
• Price / Cash Flow: 76.07
• Book Value: $6.43 per share
• Price / Book: 3.16

Miscellaneous

• Outstanding Shares: 127,730,000
• Free Float: 120,453,000
• Market Cap: $2.59 billion
• Optionable: Optionable
• Beta: 0.80